GABARAPL1 and acute myocardial infarction: Acute myocardial infarction (AMI) can induce the release of gabarapl1 from circulating endothelial cells, which can stimulate an increase in monocytes and neutrophils by recruiting NLRP3 inflammasomes, finally causing vascular inflammation during AMI (Zhang et al., 2022).